Abbott Laboratories (ABT) Earnings Date, Estimates & Call Transcripts $118.13 +0.37 (+0.31%) (As of 11/25/2024 11:41 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Abbott Laboratories Latest Earnings SummaryUpcoming Q4 Earnings DateJan. 22EstimatedActual EPS (Oct. 16) $1.21 Beat By $0.01 Consensus EPS (Oct. 16) $1.20 Abbott Laboratories announced Q3 2024 earnings on October 16, 2024, reporting an EPS of $1.21, which topped the consensus estimate of $1.20 by $0.01. Quarterly revenue rose 4.9% year-over-year to $10.64 billion, above analysts' expectations of $10.55 billion. With a trailing EPS of $3.29 and a P/E Ratio of 35.91, Abbott Laboratories' earnings are expected to grow 10.06% next year, from $4.67 to $5.14 per share. Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckABT Upcoming EarningsAbbott Laboratories' next earnings date is estimated for Wednesday, January 22, 2025, based off prior year's reporting schedules. Get Abbott Laboratories Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Abbott Laboratories and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataABT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ABT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry Research"This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined"What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about?Click here to see why experts and insiders may be preparing for the biggest financial crisis of the Abbott Laboratories Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242$0.96$1.03$1.00 Q2 20242$1.10$1.13$1.121.080 - 1.120Q3 20242$1.18$1.19$1.191.180 - 1.220Q4 20242$1.23$1.34$1.291.310 - 1.370FY 20248$4.47$4.69$4.58 Q1 20252$1.10$1.26$1.18 Q2 20252$1.26$1.28$1.27 Q3 20252$1.24$1.32$1.28 Q4 20251$1.47$1.47$1.47 FY 20257$5.07$5.33 $5.20 Abbott Laboratories Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 1/22/2025(Estimated)------- 10/16/2024Q3 2024$1.20$1.21+$0.01$1.48$10.55B$10.64B 7/18/2024Q2 2024$1.10$1.14+$0.04$1.54$10.37B$10.38B 4/17/2024Q1 2024$0.96$0.98+$0.02$1.26$9.88B$9.96B 1/24/2024Q4 2023$1.19$1.19-$1.47$10.19B$10.24B 10/18/2023Q3 2023$1.10$1.14+$0.04$1.46$9.82B$10.14B 7/20/2023Q2 2023$1.05$1.08+$0.03$1.38$9.71B$9.98B "This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined" (Ad)What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about?Click here to see why experts and insiders may be preparing for the biggest financial crisis of the 4/19/2023Q1 2023$0.98$1.03+$0.05$1.31$9.64B$9.75B 1/25/2023Q4 2022$0.90$1.03+$0.13$1.47$9.69B$10.09B Abbott Laboratories Earnings - Frequently Asked Questions When is Abbott Laboratories's earnings date? Abbott Laboratories has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 22nd, 2025 based off last year's report dates. Learn more on ABT's earnings history. What guidance has Abbott Laboratories issued on next quarter's earnings? Abbott Laboratories issued an update on its FY 2024 earnings guidance on Wednesday, October, 16th. The company provided earnings per share (EPS) guidance of 4.640-4.700 for the period, compared to the consensus EPS estimate of 4.660. The company issued revenue guidance of -. Did Abbott Laboratories beat their earnings estimates last quarter? In the previous quarter, Abbott Laboratories (NYSE:ABT) reported $1.21 earnings per share (EPS) to beat the analysts' consensus estimate of $1.20 by $0.01. Learn more on analysts' earnings estimate vs. ABT's actual earnings. How can I listen to Abbott Laboratories's earnings conference call? The conference call for Abbott Laboratories's latest earnings report can be listened to online. Listen to Conference Call How can I read Abbott Laboratories's conference call transcript? The conference call transcript for Abbott Laboratories's latest earnings report can be read online. Read Transcript How much revenue does Abbott Laboratories generate each year? Abbott Laboratories (NYSE:ABT) has a recorded annual revenue of $40.11 billion. How much profit does Abbott Laboratories generate each year? Abbott Laboratories (NYSE:ABT) has a recorded net income of $5.72 billion. ABT has generated $3.29 earnings per share over the last four quarters. What is Abbott Laboratories's price-to-earnings ratio? Abbott Laboratories (NYSE:ABT) has a trailing price-to-earnings ratio of 35.91 and a forward price-to-earnings ratio of 25.30. The price/earnings-to-growth ratio is 2.77. What is Abbott Laboratories's EPS forecast for next year? Abbott Laboratories's earnings are expected to grow from $4.67 per share to $5.14 per share in the next year, which is a 10.06% increase. ` More Earnings Resources from MarketBeat Related Companies ISRG Earnings SYK Earnings BSX Earnings MDT Earnings BDX Earnings EW Earnings RMD Earnings IDXX Earnings DXCM Earnings STE Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report "This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined" (Ad)What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about?Click here to see why experts and insiders may be preparing for the biggest financial crisis of the This page (NYSE:ABT) was last updated on 11/26/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of ...Investors Alley | Sponsored9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be wor...StockEarnings | SponsoredFormer Trump advisor issues urgent warningElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredWhat Are Buffett, Dalio, and Druckenmiller So Worried About?"This Will Be Worse Than The Great Depression, The Dot-Com Crash, And The 2008 Crisis Combined" According t...Stansberry Research | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredI was wrong. Dead wrong. Deep inside Silicon Valley the alarm bells are ringing… Jeff Bezos just sold $3 billion in Amazon stock. ...Porter & Company | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abbott Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. Share Abbott Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABT Stock Alerts